Professor Caicun Zhou: a successful step forward for international exchange on combating lung cancer

Melanie C. He

Abstract

Prof. Caicun Zhou, PhD, MD, is director of the Department of Oncology, Shanghai Pulmonary Hospital, director of Cancer Institute of Tongji University Medical School, chairman of the Oncology Department of Tongji University (Figure 1). He studied in Japan for 2 years and was a visiting scientist in USA for half a year. Prof. Zhou is a committee member of the Chinese Association of Lung Cancer and the Chinese Society of Clinical Oncology, and is a council member of the Shanghai Anti-Cancer Association, the Shanghai Pneumonology Association, and the Shanghai Oncology Association. Prof. Zhou is the Co- Editor-in-Chief of Translational Lung Cancer Research. He also serves as a member on the editorial boards of many other scientific journals, including ‘Tumor’, ‘Chinese-German Journal of Clinical Oncology’, ‘China Oncology’ and the ‘Chinese Journal of Clinical Oncology’ and also associate editor of Lung Cancer. Prof. Zhou was selected as an ‘excellent learning pioneer’ by the Science and Technology Commission of Shanghai Municipality (STCSM) in 2006, and got grants from the National 863 project and five other key research projects of the STCSM. His major research interests are in customized and targeted therapy of lung cancer, and he has published over 100 papers in scientific journals.